Vertex Pharmaceuticals Inc. logo

Vertex Pharmaceuticals Inc. (VRTX)

Market Open
5 Dec, 20:43
NASDAQ (NGS) NASDAQ (NGS)
$
455. 23
-2.13
-0.47%
$
111.27B Market Cap
30.83 P/E Ratio
0% Div Yield
547,891 Volume
14.94 Eps
$ 457.36
Previous Close
Day Range
454.46 461.88
Year Range
362.5 519.68
Want to track VRTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 61 days
Prediction: Vertex Pharmaceuticals (VRTX) Could Be The Next Stock Split Stock

Prediction: Vertex Pharmaceuticals (VRTX) Could Be The Next Stock Split Stock

Companies announce stock splits all the time, and so far this year a number of high profile companies have divvied up their shares into smaller slices.

247wallst | 1 year ago
Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today

Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today

The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $475.08, representing a +1% change from its previous close.

Zacks | 1 year ago
Vertex (VRTX) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Vertex (VRTX) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Besides Wall Street's top -and-bottom-line estimates for Vertex (VRTX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.

Zacks | 1 year ago
Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to Note

Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to Note

Vertex Pharmaceuticals (VRTX) closed at $476.37 in the latest trading session, marking a -0.28% move from the prior day.

Zacks | 1 year ago
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Vertex (VRTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 year ago
The Smartest Growth Stock to Buy With $500 Right Now

The Smartest Growth Stock to Buy With $500 Right Now

This stock might not be available for under $500 for long.

Fool | 1 year ago
Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know

Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know

Zacks.com users have recently been watching Vertex (VRTX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks | 1 year ago
Why Vertex Pharmaceuticals (VRTX) Dipped More Than Broader Market Today

Why Vertex Pharmaceuticals (VRTX) Dipped More Than Broader Market Today

In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $478.09, denoting a -1.02% change from the preceding trading day.

Zacks | 1 year ago
Vertex Pharmaceuticals (VRTX) Ascends But Remains Behind Market: Some Facts to Note

Vertex Pharmaceuticals (VRTX) Ascends But Remains Behind Market: Some Facts to Note

Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $484.94, moving +0.67% from the previous trading session.

Zacks | 1 year ago
Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock

Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock

Recently, Zacks.com users have been paying close attention to Vertex (VRTX). This makes it worthwhile to examine what the stock has in store.

Zacks | 1 year ago
Vertex Pharmaceuticals (VRTX) Registers a Bigger Fall Than the Market: Important Facts to Note

Vertex Pharmaceuticals (VRTX) Registers a Bigger Fall Than the Market: Important Facts to Note

Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $448.16, signifying a -1.57% move from its prior day's close.

Zacks | 1 year ago
Vertex Pharmaceuticals (VRTX) Surpasses Market Returns: Some Facts Worth Knowing

Vertex Pharmaceuticals (VRTX) Surpasses Market Returns: Some Facts Worth Knowing

In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $465.08, denoting a +0.48% change from the preceding trading day.

Zacks | 1 year ago
Loading...
Load More